no statement of use filed
on 18 Jan 2010
Last Applicant/ Owned by
One Merck Drive
Whitehouse Station
NJ
088890100
Serial Number
78833452 filed on 09th Mar 2006
Registration Number
N/A
Correspondent Address
Robert Peverada
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, obesity, inflammation and inflammatory diseases, respiratory diseases and disorderRead More
Pharmaceutical preparations for the treatment of addiction, urinary incontinence, diabetes, cardiovascular diseases and disorders, cerebrovascular diseases and disorders, anxiety, depression, insomnia, cognitive disorders, diseases and disorders of the central nervous system, gastrointestinal diseases and disorders, obesity, inflammation and inflammatory diseases, respiratory diseases and disorders, musculo-skeletal diseases and osteoporosis-- Anti-infective preparations; Anti-viral preparations; Immunological preparations; Analgesic preparations; Antiemetic preparations
No 78833452
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.03.03 -
Incomplete ovals
26.03.17 -
Concentric ovals and ovals within ovals
The mark consists of stylized letter "i" with two semi circle designs over the dot.
| Status Date | Action Taken |
|---|---|
| 19th Jan 2010 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 18th Jan 2010 | ABANDONMENT - NO USE STATEMENT FILED |
| 06th Mar 2009 | EXTENSION 5 GRANTED |
| 05th Mar 2009 | EXTENSION 5 FILED |
| 05th Mar 2009 | TEAS EXTENSION RECEIVED |
| 18th Dec 2008 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 18th Dec 2008 | EXTENSION 4 GRANTED |
| 05th Dec 2008 | EXTENSION 4 FILED |
| 05th Dec 2008 | TEAS EXTENSION RECEIVED |
| 20th Jun 2008 | EXTENSION 3 GRANTED |
